Bortenat Injection

Bortenat Injection

Product Details:

  • Indication Multiple myeloma, Mantle cell lymphoma
  • Dosage Form Lyophilized Powder for Injection
  • Salt Composition Bortezomib 2 mg/vial or 3.5 mg/vial
  • Feature Cytotoxic, available in sterile single-use vial
  • Ingredients Bortezomib, Mannitol
  • Application Anticancer therapy
  • Physical Color/Texture White to off-white lyophilized powder
  • Click to View more
X

Bortenat Injection Price And Quantity

  • Vial in box
  • L01XX32
  • Required with 0.9% sodium chloride
  • Worldwide
  • 179324-69-7
  • Intravenous or Subcutaneous injection
  • US FDA, EMA, and Indian DCGI approved
  • 2 mg or 3.5 mg per vial
  • Yes
  • Cytotoxic precautions required

Bortenat Injection Product Specifications

  • Multiple myeloma, Mantle cell lymphoma
  • Anticancer therapy
  • Bortezomib, Mannitol
  • Cytotoxic, available in sterile single-use vial
  • Store below 25C, protect from light
  • 2 years
  • Lyophilized Powder for Injection
  • Odorless
  • Bortezomib 2 mg/vial or 3.5 mg/vial
  • White to off-white lyophilized powder
  • Vial in box
  • L01XX32
  • Required with 0.9% sodium chloride
  • Worldwide
  • 179324-69-7
  • Intravenous or Subcutaneous injection
  • US FDA, EMA, and Indian DCGI approved
  • 2 mg or 3.5 mg per vial
  • Yes
  • Cytotoxic precautions required

Bortenat Injection Trade Information

  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Product Description

It belongs to the class of drugs called proteasome inhibitors. We run the organization by following all the code of ethics, which make us one of the reputed organizations engaged in offering Bortenat Injection. It is prescribed to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma. We source this drug from the certified vendors of the market. Bortenat Injection comes in strengths of 2mg & 3.5mg options to choose from. We offer this drug at pocket friendly prices.

Features:

  • Prevents multiplication of cancer cells
  • Blocks the action of proteasome
  • Low chance of side effects


Advanced Anticancer Treatment

Bortenat Injection is indicated for the treatment of multiple myeloma and mantle cell lymphoma. It delivers effective anticancer activity through Bortezomib, a potent proteasome inhibitor, formulated as a stable, odorless lyophilized powder. Designed for hospital and clinical use, Bortenat provides reliable therapy with global regulatory approvals and proven efficacy in hematological malignancies.


Safe and Precise Administration

Administered intravenously or subcutaneously, Bortenat Injection requires proper reconstitution with sterile 0.9% sodium chloride. Healthcare professionals must handle the drug with cytotoxic precautions to ensure safety. Its single-use vials guarantee sterility and accurate dosing, helping maintain optimal therapeutic levels while minimizing risk during preparation and administration.


Global Distribution and Quality Assurance

As an exported product with approvals from US FDA, EMA, and Indian DCGI, Bortenat Injection meets rigorous international standards. It is supplied in convenient vials, shipped in secure packaging to healthcare providers worldwide. The products extended shelf life and stringent storage requirements ensure its integrity from production in India to end users across the globe.

FAQs of Bortenat Injection:


Q: How is Bortenat Injection prepared and administered?

A: The injection must be reconstituted with sterile 0.9% sodium chloride before administration. A healthcare provider then delivers it either intravenously or subcutaneously, following cytotoxic safety protocols due to its potent anticancer properties.

Q: What conditions is Bortenat Injection used to treat?

A: Bortenat Injection is mainly indicated for multiple myeloma and mantle cell lymphoma. It acts as a proteasome inhibitor, interfering with cancer cell growth and survival, making it an essential option in oncological therapy.

Q: When should Bortenat Injection be prescribed and who can administer it?

A: A prescription from a licensed medical professional is required, and only qualified healthcare staff should prepare and administer this cytotoxic drug to ensure safe handling and accurate dosing.

Q: Where should Bortenat Injection be stored to maintain its stability?

A: Store the vials below 25C, protected from light. This keeps the lyophilized powder stable and potent for up to 2 years, as indicated by the shelf life.

Q: What precautions are necessary in handling Bortenat Injection?

A: Due to its cytotoxic nature, special precautions such as using gloves, masks, and designated work areas are mandatory in preparation and administration to protect healthcare workers from exposure.

Q: What are the benefits of using Bortenat Injection in cancer therapy?

A: Bortenat Injection offers targeted action against malignant cells, with proven efficacy for hematological cancers. Supported by global regulatory approvals, it provides reliable, standardized treatment for serious oncological indications.

Q: How is Bortenat Injection packaged for export and distribution?

A: It is available in sterile, single-use vials packed in boxes, ensuring product integrity during transit. Distributors, exporters, and traders ensure it reaches healthcare facilities worldwide under compliant shipping conditions.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Injections' category



We Mainly Deal in International Market.
Back to top